Literature DB >> 16551243

Osteoimmunology: interplay between the immune system and bone metabolism.

Matthew C Walsh1, Nacksung Kim, Yuho Kadono, Jaerang Rho, Soo Young Lee, Joseph Lorenzo, Yongwon Choi.   

Abstract

Studies of bone and the immune system have converged in recent years under the banner of osteoimmunology. The immune system is spawned in the bone marrow reservoir, and investigators now recognize that important niches also exist there for memory lymphocytes. At the same time, various factors produced during immune responses are capable of profoundly affecting regulation of bone. Mechanisms have evolved to prevent excessive interference by the immune system with bone homeostasis, yet pathologic bone loss is a common sequela associated with autoimmunity and cancer. There are also developmental links, or parallels, between bone and the immune system. Cells that regulate bone turnover share a common precursor with inflammatory immune cells and may restrict themselves anatomically, in part by utilizing a signaling network analogous to lymphocyte costimulation. Efforts are currently under way to further characterize how these two organ systems overlap and to develop therapeutic strategies that benefit from this understanding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551243     DOI: 10.1146/annurev.immunol.24.021605.090646

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  220 in total

1.  Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes.

Authors:  Se Hwan Mun; Na Young Ko; Hyuk Soon Kim; Jie Wan Kim; Do Kyun Kim; A-Ram Kim; Seung Hyun Lee; Yong-Gil Kim; Chang Keun Lee; Seoung Hoon Lee; Bo Kyung Kim; Michael A Beaven; Young Mi Kim; Wahn Soo Choi
Journal:  Cell Mol Life Sci       Date:  2010-06-08       Impact factor: 9.261

2.  The transmembrane adaptor protein, linker for activation of T cells (LAT), regulates RANKL-induced osteoclast differentiation.

Authors:  Kabsun Kim; Jung Ha Kim; Jang Bae Moon; Jongwon Lee; Han Bok Kwak; Yong-Wook Park; Nacksung Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

Review 3.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

4.  Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.

Authors:  Hui Zhang; Yuefang Huang; Shuang Wang; Rong Fu; Chaohuan Guo; Hongyue Wang; Jijun Zhao; Felicia Gaskin; Jingxian Chen; Niansheng Yang; Shu Man Fu
Journal:  J Autoimmun       Date:  2015-08-28       Impact factor: 7.094

5.  The influence of interleukin-32γ on osteoclastogenesis with a focus on fusion-related genes.

Authors:  Yong-Gil Kim; Min Wook So; Bon San Koo; Eun-Ju Chang; Seok Jong Song; Chang-Keun Lee; Bin Yoo
Journal:  J Clin Immunol       Date:  2011-11-09       Impact factor: 8.317

6.  Crystallization and preliminary X-ray analysis of mouse RANK and its complex with RANKL.

Authors:  Thomas S Walter; Changzhen Liu; Peng Huang; Shiqian Zhang; Lucy R Wedderburn; Bin Gao; Raymond J Owens; David I Stuart; Peifu Tang; Jingshan Ren
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-05-22

7.  Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation.

Authors:  Taesoo Kim; Kabsun Kim; Seoung Hoon Lee; Hong-Seob So; Junwon Lee; Nacksung Kim; Yongwon Choi
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

8.  Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis.

Authors:  Roba M Talaat; Asmaa Sidek; Ahmed Mosalem; Ahmed Kholief
Journal:  Inflammopharmacology       Date:  2015-04-25       Impact factor: 4.473

Review 9.  Altered bone remodeling in psoriatic arthritis.

Authors:  Kofi A Mensah; Edward M Schwarz; Christopher T Ritchlin
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

10.  In vivo impact of a 4 bp deletion mutation in the DLX3 gene on bone development.

Authors:  S J Choi; G D Roodman; J Q Feng; I S Song; K Amin; P S Hart; J T Wright; N Haruyama; T C Hart
Journal:  Dev Biol       Date:  2008-10-25       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.